Literature DB >> 27794505

Imaging visceral leishmaniasis in real time with golden hamster model: Monitoring the parasite burden and hamster transcripts to further characterize the immunological responses of the host.

Eline Rouault1, Hervé Lecoeur1, Asma Ben Meriem1, Paola Minoprio1, Sophie Goyard2, Thierry Lang3.   

Abstract

Characterizing the clinical, immunological and parasitological features associated with visceral leishmaniasis is complex. It involves recording in real time and integrating quantitative multi-parametric data sets from parasite infected host tissues. Although several models have been used, hamsters are considered the bona fide experimental model for Leishmania donovani studies. To study visceral leishmaniasis in hamsters we generated virulent transgenic L. donovani that stably express a reporter luciferase protein. Two complementary methodologies were combined to follow the infectious process: in vivo imaging using luciferase-expressing Leishmania and real time RT-PCR to quantify both Leishmania and host transcripts. This approach allows us: i) to assess the clinical outcome of visceral leishmaniasis by individual monitoring of hamster weight, ii) to follow the parasite load in several organs by real time analysis of the bioluminescence in vivo and through real time quantitative PCR analysis of amastigote parasite transcript abundance ex vivo, iii) to evaluate the immunological responses triggered by the infection by quantifying hamster transcripts on the same samples and iv) to limit the number of hamsters selected for further analysis. The overall data highlight a correlation between the transcriptional cytokine signatures of hamster affected tissues and the amastigote burden fluctuations, thus providing new insights into the immunopathological process driven by L. donovani in the tissues of mammalian hosts. Finally, they suggest organ-specific immune responses. Copyright Â
© 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Bioluminescence; Hamsters; Luciferase; Virulent transgenic Leishmania donovani; Visceral leishmaniasis

Mesh:

Substances:

Year:  2016        PMID: 27794505     DOI: 10.1016/j.parint.2016.10.020

Source DB:  PubMed          Journal:  Parasitol Int        ISSN: 1383-5769            Impact factor:   2.230


  8 in total

1.  New insights into experimental visceral leishmaniasis: Real-time in vivo imaging of Leishmania donovani virulence.

Authors:  Guilherme D Melo; Sophie Goyard; Hervé Lecoeur; Eline Rouault; Pascale Pescher; Laurence Fiette; Alexandre Boissonnas; Paola Minoprio; Thierry Lang
Journal:  PLoS Negl Trop Dis       Date:  2017-09-25

2.  Unveiling Cerebral Leishmaniasis: parasites and brain inflammation in Leishmania donovani infected mice.

Authors:  Guilherme D Melo; Sophie Goyard; Laurence Fiette; Alexandre Boissonnas; Christophe Combadiere; Gisele F Machado; Paola Minoprio; Thierry Lang
Journal:  Sci Rep       Date:  2017-08-16       Impact factor: 4.379

3.  Development of (6 R)-2-Nitro-6-[4-(trifluoromethoxy)phenoxy]-6,7-dihydro-5 H-imidazo[2,1- b][1,3]oxazine (DNDI-8219): A New Lead for Visceral Leishmaniasis.

Authors:  Andrew M Thompson; Patrick D O'Connor; Andrew J Marshall; Adrian Blaser; Vanessa Yardley; Louis Maes; Suman Gupta; Delphine Launay; Stephanie Braillard; Eric Chatelain; Baojie Wan; Scott G Franzblau; Zhenkun Ma; Christopher B Cooper; William A Denny
Journal:  J Med Chem       Date:  2018-03-06       Impact factor: 7.446

Review 4.  In-vivo monitoring of infectious diseases in living animals using bioluminescence imaging.

Authors:  Pinar Avci; Mahdi Karimi; Magesh Sadasivam; Wanessa C Antunes-Melo; Elisa Carrasco; Michael R Hamblin
Journal:  Virulence       Date:  2017-12-08       Impact factor: 5.882

Review 5.  Challenges in drug discovery targeting TriTryp diseases with an emphasis on leishmaniasis.

Authors:  Laura M Alcântara; Thalita C S Ferreira; Fernanda R Gadelha; Danilo C Miguel
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2018-09-28       Impact factor: 4.077

6.  Establishment, optimisation and quantitation of a bioluminescent murine infection model of visceral leishmaniasis for systematic vaccine screening.

Authors:  Han Boon Ong; Simon Clare; Adam Jonathan Roberts; Mary Edythe Wilson; Gavin James Wright
Journal:  Sci Rep       Date:  2020-03-13       Impact factor: 4.379

7.  Murine infection with bioluminescent Leishmania infantum axenic amastigotes applied to drug discovery.

Authors:  David Mendes Costa; Pedro Cecílio; Nuno Santarém; Anabela Cordeiro-da-Silva; Joana Tavares
Journal:  Sci Rep       Date:  2019-12-12       Impact factor: 4.379

8.  The relationship between fleas and small mammals in households of the Western Yunnan Province, China.

Authors:  Jia-Xiang Yin; Xiao-Ou Cheng; Yun-Yan Luo; Qiu-Fang Zhao; Zhao-Fei Wei; Dan-Dan Xu; Meng-Di Wang; Yun Zhou; Xiu-Fang Wang; Zheng-Xiang Liu
Journal:  Sci Rep       Date:  2020-10-07       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.